X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5117) 5117
androstadienes - pharmacology (4390) 4390
humans (3083) 3083
animals (2762) 2762
enzyme inhibitors - pharmacology (1924) 1924
wortmannin (1521) 1521
phosphatidylinositol 3-kinases - antagonists & inhibitors (1403) 1403
male (1343) 1343
phosphatidylinositol 3-kinases - metabolism (1320) 1320
biochemistry & molecular biology (1236) 1236
rats (1175) 1175
phosphorylation (1130) 1130
female (1113) 1113
mice (1020) 1020
chromones - pharmacology (914) 914
morpholines - pharmacology (914) 914
cells, cultured (867) 867
signal transduction (845) 845
fluticasone (785) 785
phosphatidylinositol 3-kinase (774) 774
cell biology (746) 746
cell line (726) 726
pharmacology & pharmacy (715) 715
activation (694) 694
androstadienes - administration & dosage (630) 630
signal transduction - drug effects (615) 615
dose-response relationship, drug (593) 593
androstadienes - therapeutic use (571) 571
adult (534) 534
enzyme activation (485) 485
time factors (485) 485
apoptosis (449) 449
middle aged (444) 444
expression (430) 430
insulin - pharmacology (420) 420
oncology (419) 419
proto-oncogene proteins c-akt (418) 418
phosphoinositide 3-kinase (412) 412
proto-oncogene proteins c-akt - metabolism (405) 405
cells (394) 394
abridged index medicus (386) 386
flavonoids - pharmacology (383) 383
proto-oncogene proteins - metabolism (379) 379
transfection (378) 378
phosphorylation - drug effects (373) 373
administration, inhalation (369) 369
asthma (365) 365
signal transduction - physiology (364) 364
phosphatidylinositol 3-kinases (358) 358
immunology (355) 355
tumor cells, cultured (355) 355
protein kinase inhibitors - pharmacology (354) 354
protein-serine-threonine kinases - metabolism (346) 346
blotting, western (343) 343
apoptosis - drug effects (339) 339
asthma - drug therapy (337) 337
rats, sprague-dawley (336) 336
kinetics (334) 334
cell line, tumor (307) 307
enzyme activation - drug effects (305) 305
insulin (304) 304
endocrinology & metabolism (294) 294
akt (289) 289
inhibition (288) 288
phosphatidylinositol 3-kinases - physiology (277) 277
protein-serine-threonine kinases (274) 274
aged (266) 266
fluticasone propionate (264) 264
research (260) 260
proteins (256) 256
in vitro techniques (255) 255
signal-transduction (254) 254
in-vitro (251) 251
protein-kinase (249) 249
phosphotransferases - antagonists & inhibitors (247) 247
respiratory system (246) 246
double-blind method (242) 242
androstadienes - adverse effects (241) 241
physiology (240) 240
biophysics (239) 239
corticosteroids (237) 237
receptor (235) 235
rats, wistar (233) 233
kinase (231) 231
calcium - metabolism (230) 230
mitogen-activated protein kinases - metabolism (230) 230
phosphotransferases - metabolism (224) 224
physiological aspects (221) 221
breast neoplasms - drug therapy (214) 214
albuterol - analogs & derivatives (213) 213
sirolimus - pharmacology (211) 211
adolescent (207) 207
treatment outcome (207) 207
analysis (206) 206
neurosciences (206) 206
protein kinase c - metabolism (202) 202
growth-factor (200) 200
androstadienes - pharmacokinetics (199) 199
cell survival - drug effects (199) 199
protein (199) 199
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5207) 5207
Chinese (26) 26
Japanese (20) 20
Russian (11) 11
French (9) 9
German (9) 9
Italian (4) 4
Polish (3) 3
Spanish (3) 3
Ukrainian (3) 3
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Pharmacology, ISSN 0007-1188, 12/2002, Volume 137, Issue 7, pp. 1021 - 1030
The mechanism(s) by which vascular endothelial growth factor (VEGF) induces endothelial nitric oxide synthase (eNOS) activation remain(s) unclear up to a... 
NO | eNOS | 2 | PAF | PI3K | PLA | VEGF | PLC | PKC | PROTEIN-KINASE-C | ANGIOGENESIS | PERMEABILITY | PHOSPHORYLATION | NITRIC-OXIDE SYNTHASE | CALMODULIN | CALCIUM | PAF SYNTHESIS | PHARMACOLOGY & PHARMACY | PLATELET-ACTIVATING-FACTOR | GROWTH-FACTOR | Endothelium, Vascular - cytology | Vascular Endothelial Growth Factors | Platelet Activating Factor - pharmacology | Protein-Serine-Threonine Kinases | Type C Phospholipases - metabolism | Endothelium, Vascular - drug effects | Endothelial Growth Factors - pharmacology | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Receptors, Cell Surface - antagonists & inhibitors | Lactones - pharmacology | Platelet Membrane Glycoproteins - antagonists & inhibitors | Calcium - antagonists & inhibitors | Time Factors | Cattle | Protein Kinase C - metabolism | Phosphorylation - drug effects | Chromones - pharmacology | Enzyme Inhibitors - pharmacology | Nitric Oxide Synthase Type III | Receptors, G-Protein-Coupled | Chelating Agents - pharmacology | Serine - metabolism | 1-Methyl-3-isobutylxanthine - pharmacology | Ginkgolides | Platelet Activating Factor - metabolism | Cyclic GMP - metabolism | Endothelium, Vascular - metabolism | Intercellular Signaling Peptides and Proteins - pharmacology | Nitric Oxide Synthase - metabolism | Vascular Endothelial Growth Factor A | Maleimides - pharmacology | Nitric Oxide Synthase - antagonists & inhibitors | Phosphatidylinositol 3-Kinases - metabolism | Nitroprusside - pharmacology | Type C Phospholipases - antagonists & inhibitors | Dose-Response Relationship, Drug | Egtazic Acid - analogs & derivatives | Indoles - pharmacology | Lymphokines - pharmacology | Nitric Oxide Donors - pharmacology | Ionophores - pharmacology | NG-Nitroarginine Methyl Ester - pharmacology | Proto-Oncogene Proteins - metabolism | Cells, Cultured | Morpholines - pharmacology | Protein Kinase C - antagonists & inhibitors | Calcimycin - pharmacology | Proto-Oncogene Proteins c-akt | Animals | Egtazic Acid - pharmacology | Androstadienes - pharmacology | Diterpenes | Signal Transduction - physiology | Nitric Oxide - metabolism | Index Medicus | Papers | PLA2
Journal Article
Circulation Research: Journal of the American Heart Association, ISSN 0009-7330, 04/2004, Volume 94, Issue 7, pp. 960 - 966
ABSTRACT—Glycogen synthase kinase (GSK) inhibition produced by ischemic preconditioning has been previously shown to be regulated through... 
Phosphatidylinositol-3 kinase | Reperfusion | Glycogen synthase kinase | Target of rapamycin | Opioids | LOCALIZATION | ACTIVATION | CARDIAC & CARDIOVASCULAR SYSTEMS | PROTECTION | PHOSPHORYLATION | phosphatidylinositol-3 kinase | PHOSPHATIDYLINOSITOL 3-KINASE | CELL-SURVIVAL | KINASE-3-BETA | INSULIN | P70S6 KINASE | INDUCED DELAYED CARDIOPROTECTION | glycogen synthase kinase | PERIPHERAL VASCULAR DISEASE | target of rapamycin | HEMATOLOGY | reperfusion | opioids | Glycogen Synthase Kinase 3 - physiology | Maleimides - pharmacology | Receptors, Retinoic Acid - physiology | Glycogen Synthase Kinase 3 beta | Male | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Receptors, Thyroid Hormone - antagonists & inhibitors | Aminophenols - pharmacology | Cardiotonic Agents - therapeutic use | Myocardial Infarction - pathology | Indoles - pharmacology | Benzamides - pharmacology | Chromones - pharmacology | Nuclear Receptor Subfamily 1, Group F, Member 3 | Morphine - pharmacology | Glycogen Synthase Kinase 3 - antagonists & inhibitors | Morpholines - pharmacology | Rats | Receptors, Retinoic Acid - antagonists & inhibitors | Cardiotonic Agents - pharmacology | Myocardial Infarction - metabolism | Receptors, Opioid, delta - drug effects | Piperazines - pharmacology | Rats, Sprague-Dawley | Receptors, Thyroid Hormone - physiology | Sirolimus - pharmacology | Animals | Androstadienes - pharmacology | Signal Transduction - drug effects | Narcotic Antagonists - pharmacology | Phosphatidylinositol 3-Kinases - physiology | Premedication | Index Medicus
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 10/2012, Volume 167, Issue 4, pp. 775 - 786
BACKGROUND AND PURPOSE Patients with chronic obstructive pulmonary disease (COPD) show a poor response to corticosteroids, which has been linked to oxidative... 
salmeterol | corticosteroid | severe asthma | PI3Kδ | formoterol | oxidative stress | COPD | CELLS | COMBINATION THERAPY | INHALED CORTICOSTEROIDS | AIRWAY INFLAMMATION | BUDESONIDE | ADRENERGIC AGONISTS | INTERLEUKIN-8 | ASTHMA CONTROL | OBSTRUCTIVE PULMONARY-DISEASE | PHARMACOLOGY & PHARMACY | PI3Kd | Ethanolamines - pharmacology | Asthma - metabolism | Formoterol Fumarate | Albuterol - pharmacology | Humans | Middle Aged | Oxidative Stress - physiology | Male | Fluticasone | Adrenergic beta-2 Receptor Agonists - pharmacology | 1-Phosphatidylinositol 4-Kinase - metabolism | Young Adult | Dexamethasone - pharmacology | U937 Cells | Adult | Female | Interleukin-8 - metabolism | Pulmonary Disease, Chronic Obstructive - metabolism | Chromones - pharmacology | Salmeterol Xinafoate | Adenine - analogs & derivatives | Leukocytes, Mononuclear - drug effects | Hydrogen Peroxide - pharmacology | Adrenal Cortex Hormones - pharmacology | Albuterol - analogs & derivatives | Morpholines - pharmacology | 1-Phosphatidylinositol 4-Kinase - antagonists & inhibitors | Adenine - pharmacology | Drug Resistance - drug effects | Receptors, Adrenergic, beta-2 - metabolism | Budesonide - pharmacology | Androstadienes - pharmacology | Aged | Quinazolines - pharmacology | Hydrogen peroxide | Dexamethasone | Asthma | Steroids | Oxidative stress | Chronic obstructive pulmonary disease | Index Medicus | Research Papers
Journal Article
American Journal of Physiology - Cell Physiology, ISSN 0363-6143, 07/2017, Volume 313, Issue 1, pp. C118 - C129
Parathyroid hormone (PTH), a pleiotropic hormone that maintains mineral homeostasis, is also essential for controlling pH balance and ion transport across... 
Na | Anion secretion | Impedance analysis | exchanger | H | Ussing chamber | Potassium channel | anion secretion | PHYSIOLOGY | Na+/H+ exchanger | RAT | EXCHANGER NHE-3 | PROTEIN-KINASE | MEMBRANE REPAIR | CELL BIOLOGY | TRANSPORT | impedance analysis | HCO3-SECRETION | potassium channel | PARATHYROID-HORMONE | CL-SECRETION | CELL-LINE | BICARBONATE SECRETION | Potassium - metabolism | Sodium-Potassium-Exchanging ATPase - genetics | Calcium - metabolism | Humans | Parathyroid Hormone - pharmacology | Electric Conductivity | Phosphatidylinositol 3-Kinases - metabolism | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Potassium Channels, Calcium-Activated - genetics | Isoquinolines - pharmacology | Chlorides - metabolism | Potassium Channels, Calcium-Activated - metabolism | Ion Transport - drug effects | Chromones - pharmacology | Action Potentials - drug effects | Pyrazoles - pharmacology | Caco-2 Cells | Cystic Fibrosis Transmembrane Conductance Regulator - antagonists & inhibitors | Sodium-Potassium-Exchanging ATPase - antagonists & inhibitors | Acetazolamide - pharmacology | Chlorides - pharmacology | Colforsin - pharmacology | Clotrimazole - pharmacology | Morpholines - pharmacology | Cystic Fibrosis Transmembrane Conductance Regulator - metabolism | Carbonic Anhydrase Inhibitors - pharmacology | Sulfonamides - pharmacology | Barium Compounds - pharmacology | Phosphatidylinositol 3-Kinases - genetics | Sodium-Potassium-Exchanging ATPase - metabolism | Androstadienes - pharmacology | Phosphorus - metabolism | Wortmannin | Bicarbonates - metabolism | Cystic Fibrosis Transmembrane Conductance Regulator - genetics | Potassium Channels, Calcium-Activated - antagonists & inhibitors | Hydrogen-Ion Concentration | Index Medicus
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 07/2004, Volume 24, Issue 28, pp. 6352 - 6361
Hippocampal long-term depression (LTD) is a long-lasting decrease in synaptic strength that is most commonly studied at glutamatergic inputs to pyramidal cells... 
CA1 | Phosphorylation | Protein kinase | Hippocampus | Synaptic plasticity | Translation initiation | MAMMALIAN TARGET | MESSENGER-RNA TRANSLATION | hippocampus | PHOSPHATIDYLINOSITOL 3-KINASE | translation initiation | HIPPOCAMPAL CA1 REGION | AREA CA1 | NEUROSCIENCES | protein kinase | X MENTAL-RETARDATION | PROTEIN-KINASE B | P70 S6 KINASE | synaptic plasticity | phosphorylation | DHPG-INDUCED LTD | Glycine - analogs & derivatives | Pyramidal Cells - metabolism | Synaptosomes - drug effects | Receptors, Metabotropic Glutamate - physiology | Male | Tacrolimus - analogs & derivatives | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Resorcinols - pharmacology | Protein Processing, Post-Translational - drug effects | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Tacrolimus - pharmacology | Receptor, Metabotropic Glutamate 5 | Pyramidal Cells - drug effects | Phosphorylation - drug effects | Chromones - pharmacology | Pyramidal Cells - ultrastructure | 3-Phosphoinositide-Dependent Protein Kinases | Dendrites - drug effects | Dendrites - metabolism | Long-Term Synaptic Depression - physiology | Protein Kinases - drug effects | Protein-Serine-Threonine Kinases - physiology | Synaptosomes - physiology | Mice, Inbred C57BL | Enzyme Inhibitors - pharmacology | Morpholines - pharmacology | Excitatory Amino Acid Agonists - pharmacology | Hippocampus - cytology | Sirolimus - pharmacology | Proto-Oncogene Proteins c-akt | Animals | Androstadienes - pharmacology | Glycine - pharmacology | Signal Transduction - drug effects | Protein Kinases - physiology | Wortmannin | Proto-Oncogene Proteins - physiology | Benzoates - pharmacology | Phosphatidylinositol 3-Kinases - physiology | Mice | Pyridines - pharmacology | TOR Serine-Threonine Kinases | Hippocampus - physiology | Receptors, Metabotropic Glutamate - agonists | Index Medicus | Cellular | Molecular
Journal Article
Journal of Endocrinology, ISSN 0022-0795, 08/2002, Volume 174, Issue 2, pp. 233 - 246
Glucose-dependent insulinotropic polypeptide (GIP) acts as a glucose-dependent growth factor for beta-cells. Here we show that GIP and glucose also act... 
PATHWAYS | IGF-I | RECEPTOR TYROSINE KINASES | ACTIVATED PROTEIN-KINASE | PHOSPHATIDYLINOSITOL 3-KINASE | MAP KINASE | ENDOCRINOLOGY & METABOLISM | ELEMENT-BINDING PROTEIN | INS-1 CELLS | GROWTH-FACTOR | FACTOR-I | Apoptosis - drug effects | Calcium - metabolism | Humans | Maleimides - pharmacology | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | MAP Kinase Kinase 1 | Isoquinolines - pharmacology | Deoxyglucose - pharmacology | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Indoles - pharmacology | Flavonoids - pharmacology | Cyclic AMP-Dependent Protein Kinases - antagonists & inhibitors | Gastric Inhibitory Polypeptide - pharmacology | B-Lymphocytes - metabolism | Cell Line | Enzyme Inhibitors - pharmacology | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Arginase - genetics | Protein Kinase C - antagonists & inhibitors | Chelating Agents - pharmacology | Calcium-Calmodulin-Dependent Protein Kinases - antagonists & inhibitors | Sulfonamides - pharmacology | Egtazic Acid - pharmacology | MAP Kinase Signaling System - drug effects | Mitosis - drug effects | Androstadienes - pharmacology | Signal Transduction - drug effects | Glucokinase - antagonists & inhibitors | Plasmids | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology | Wortmannin | Genistein - pharmacology | Glucose - metabolism | Alloxan - pharmacology | Benzylamines - pharmacology | Protein-Tyrosine Kinases - antagonists & inhibitors | Index Medicus
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 2007, Volume 24, Issue 8, pp. 1590 - 1598
Knowledge about the uptake mechanism and subsequent intracellular routing of non-viral gene delivery systems is important for the development of more efficient... 
Biomedical Engineering | Biochemistry, general | gene delivery | Biomedicine | Pharmacy | cationic polymers | Medical Law | endocytosis | Pharmacology/Toxicology | caveolae | Gene delivery | Endocytosis | Cationic polymers | Caveolae | PATHWAYS | POLYPLEXES | INTRACELLULAR FATE | CHOLESTEROL | POLYETHYLENIMINE | CHEMISTRY, MULTIDISCIPLINARY | DELIVERY | INTERNALIZATION | MEDIATED ENDOCYTOSIS | MACROPINOCYTOSIS | PHARMACOLOGY & PHARMACY | EFFICIENCY | Luciferases - metabolism | Nocodazole - pharmacology | Cercopithecus aethiops | Caveolae - drug effects | Methacrylates - chemistry | beta-Cyclodextrins - pharmacology | Clathrin-Coated Vesicles - metabolism | Luciferases - genetics | Flow Cytometry | Macromolecular Substances - chemistry | Transfection - methods | Polyethyleneimine - chemistry | Biological Transport - drug effects | Fluorescent Dyes - chemistry | Polyamines - chemistry | Caveolae - metabolism | Cholera Toxin - metabolism | Endocytosis - drug effects | Enzyme Inhibitors - pharmacology | Nylons - chemistry | Chlorpromazine - pharmacology | Clathrin-Coated Vesicles - drug effects | DNA - chemistry | Animals | Androstadienes - pharmacology | Genistein - pharmacology | Macromolecular Substances - pharmacokinetics | Cholera Toxin - pharmacokinetics | Transferrin - pharmacokinetics | Transferrin - metabolism | COS Cells | Macromolecular Substances - metabolism | Microscopy, Fluorescence | Gene expression | Cholera toxin | Cellular biology | Deoxyribonucleic acid | DNA | Pharmacology | Gene therapy | Polymers | Index Medicus | Research Paper
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 06/2011, Volume 660, Issue 2-3, pp. 394 - 401
Journal Article
FASEB Journal, ISSN 0892-6638, 08/2004, Volume 18, Issue 11, pp. 1309 - 1311
Accumulation of inflammatory mononuclear phagocytes in Alzheimer's senile plaques, a hallmark of the innate immune response to beta-amyloid fibrils, can... 
ACTIVATION | G-protein coupled receptors | Alzheimer disease | ALZHEIMERS-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | immunosuppression | NEUTROPHILS | sphingosine-1-phosphate receptors | MESSENGER | PEPTIDE | CELL BIOLOGY | FIBRILS | MICROGLIA | SPHINGOSINE-1-PHOSPHATE | BIOLOGY | leukocytes | T-CELL CHEMOTAXIS | 1-PHOSPHATE | Phosphotransferases (Alcohol Group Acceptor) - physiology | Amyloid beta-Peptides - pharmacology | Humans | Maleimides - pharmacology | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | RNA, Messenger - biosynthesis | Bombesin - pharmacology | Chemotaxis, Leukocyte - drug effects | Protein Processing, Post-Translational - drug effects | Vasoactive Intestinal Peptide - pharmacology | Neuropeptides - pharmacology | N-Formylmethionine Leucyl-Phenylalanine - pharmacology | Receptors, Lysosphingolipid - genetics | Indoles - pharmacology | Cholera Toxin - pharmacology | Heterotrimeric GTP-Binding Proteins - physiology | Phosphorylation - drug effects | Drug Evaluation, Preclinical | Pertussis Toxin - pharmacology | Propylene Glycols - pharmacology | Leukocytes, Mononuclear - drug effects | Calcitonin Gene-Related Peptide - pharmacology | Enzyme Inhibitors - pharmacology | Secretogranin II | Fingolimod Hydrochloride | Receptors, Lysosphingolipid - physiology | Tyrphostins - pharmacology | 1-Methyl-3-isobutylxanthine - pharmacology | Gene Expression Regulation - drug effects | Sphingosine - pharmacology | Cell Movement - drug effects | Phosphotransferases (Alcohol Group Acceptor) - antagonists & inhibitors | Sphingosine - analogs & derivatives | Androstadienes - pharmacology | Receptors, Lysosphingolipid - agonists | Leukocytes, Mononuclear - cytology | Protein Kinase Inhibitors - pharmacology | Immunologic Factors - pharmacology | Receptors, Lysosphingolipid - biosynthesis | Staurosporine - pharmacology | Amyloid beta-Protein Precursor - pharmacology | Index Medicus
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 05/2010, Volume 30, Issue 5, pp. 992 - 999
OBJECTIVE—Selective estrogen receptor modulators (SERMs) inhibit constriction of mammalian conduit arteries. However, it is unknown whether SERMs at... 
Endothelial nitric oxide synthase | Mesenteric artery | Raloxifene | Selective estrogen receptor modulator | Myogenic tone | CA2+ INFLUX | myogenic tone | CARDIOVASCULAR EVENTS | RELAXATION | raloxifene | CORONARY-ARTERY | mesenteric artery | IN-VITRO | ESTROGEN | endothelial nitric oxide synthase | selective estrogen receptor modulator | PERIPHERAL VASCULAR DISEASE | CEREBRAL-ARTERIES | POSTMENOPAUSAL WOMEN | HEMATOLOGY | RECEPTOR MODULATOR RALOXIFENE | Raloxifene Hydrochloride - pharmacology | Estradiol - analogs & derivatives | Phosphorylation | Estrogen Antagonists - pharmacology | Male | Mesenteric Arteries - drug effects | Apamin - pharmacology | Dose-Response Relationship, Drug | Time Factors | Charybdotoxin - pharmacology | Vascular Resistance - drug effects | Female | Blood Pressure - drug effects | Nitric Oxide Synthase Type III - metabolism | Chromones - pharmacology | Estradiol - pharmacology | Potassium Channel Blockers - pharmacology | NG-Nitroarginine Methyl Ester - pharmacology | Vasodilator Agents - pharmacology | Ovariectomy | Enzyme Inhibitors - pharmacology | Morpholines - pharmacology | Rats | Rats, Sprague-Dawley | Nitric Oxide Synthase Type III - antagonists & inhibitors | Animals | Androstadienes - pharmacology | Calcium Signaling - drug effects | Sex Factors | Protein Kinase Inhibitors - pharmacology | Enzyme Activation | Vasodilation - drug effects | In Vitro Techniques | Nitric Oxide - metabolism | Mesenteric Arteries - enzymology | Selective Estrogen Receptor Modulators - pharmacology | Index Medicus
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 08/2008, Volume 128, Issue 8, pp. 2013 - 2023
The RAS–RAF–MEK–ERK and PI3K–AKT–mTOR signaling pathways are activated through multiple mechanisms and appear to play a major role in melanoma progression.... 
MAMMALIAN TARGET | RAPAMYCIN | PATHWAYS | APOPTOSIS | HUMAN-LEUKEMIA-CELLS | CUTANEOUS MELANOMA | DOWN-REGULATION | AKT | BCL-2 FAMILY-MEMBERS | UP-REGULATION | DERMATOLOGY | Niacinamide - analogs & derivatives | Mitogen-Activated Protein Kinase Kinases - genetics | Skin Neoplasms - drug therapy | Nitriles - pharmacology | Apoptosis - drug effects | Humans | Multiprotein Complexes | Phenylurea Compounds | Mechanistic Target of Rapamycin Complex 1 | Transcription Factors - drug effects | Proteins | Proto-Oncogene Proteins c-bcl-2 - metabolism | Benzenesulfonates - pharmacology | Flavonoids - pharmacology | Chromones - pharmacology | Skin Neoplasms - pathology | Butadienes - pharmacology | Neoplasm Invasiveness | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Morpholines - pharmacology | Transcription Factors - antagonists & inhibitors | Melanoma - pathology | Transcription Factors - genetics | Down-Regulation - drug effects | Sirolimus - pharmacology | Androstadienes - pharmacology | Signal Transduction - drug effects | Melanoma - drug therapy | Myeloid Cell Leukemia Sequence 1 Protein | Mitogen-Activated Protein Kinase Kinases - drug effects | Cell Line, Tumor | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | TOR Serine-Threonine Kinases | Proto-Oncogene Proteins c-bcl-2 - genetics | Index Medicus
Journal Article
Journal Article
Learning and Memory, ISSN 1072-0502, 08/2017, Volume 24, Issue 8, pp. 341 - 357
High-frequency stimulation of the medial perforant path triggers robust phosphorylation of ribosomal protein S6 (rpS6) in activated dendritic domains and... 
MAMMALIAN TARGET | MESSENGER-RNA TRANSLATION | CAP-DEPENDENT TRANSLATION | PHOSPHATIDYLINOSITOL 3-KINASE | GYRUS IN-VIVO | KINASE | LONG-TERM POTENTIATION | RAT HIPPOCAMPAL SLICES | DENTATE GYRUS | INHIBITOR | NEUROSCIENCES | Brain | Neurological Organization | Cytology | Stimulation | Biochemistry | Inhibition | Drug Use | Cell Body - drug effects | Nitriles - pharmacology | Ribosomal Protein S6 Kinases - metabolism | TOR Serine-Threonine Kinases - metabolism | Receptors, N-Methyl-D-Aspartate - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Hippocampus - drug effects | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | TOR Serine-Threonine Kinases - antagonists & inhibitors | Synapses - metabolism | Female | Phosphorylation - drug effects | Benzopyrans - pharmacology | Chromones - pharmacology | Membrane Potentials - drug effects | Dendrites - drug effects | Dendrites - metabolism | Synapses - drug effects | Butadienes - pharmacology | Enzyme Inhibitors - pharmacology | Morpholines - pharmacology | Cell Body - metabolism | Imidazoles - pharmacology | Membrane Potentials - physiology | Piperazines - pharmacology | Rats, Sprague-Dawley | Sirolimus - pharmacology | Hippocampus - metabolism | Animals | MAP Kinase Signaling System - drug effects | Androstadienes - pharmacology | Ribosomal Protein S6 - metabolism | Monosaccharides - pharmacology | Ribosomal Protein S6 Kinases - antagonists & inhibitors | Index Medicus
Journal Article